Effect of sperm DNA fragmentation on the clinical outcomes for in vitro fertilization and intracytoplasmic sperm injection in women with different ovarian reserves  by Jin, Jianyuan et al.
Effect of sperm DNA fragmentation
on the clinical outcomes for in vitro
fertilization and intracytoplasmic
sperm injection in women with
different ovarian reserves
Jianyuan Jin, M.S., Chengshuang Pan, M.D., Qianjin Fei, M.D., Wuhua Ni, M.S., Xu Yang, M.S.,
Liya Zhang, M.S., and Xuefeng Huang, M.D., Ph.D.
Reproductive Medicine Center, First Afﬁliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's
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Design: Retrospective clinical study.
Setting: University-afﬁliated tertiary teaching hospital.
Patient(s): A total of 2,865 consecutive couples undergoing their ﬁrst in vitro fertilization (IVF) or intracytoplasmic sperm injection
(ICSI) cycle.
Intervention(s): SDF assessed using sperm chromatin dispersion in sperm samples 1–2 months before treatment.
Main Outcome Measure(s): SDF, IVF, and ICSI outcomes.
Result(s): The grouping criteria were [1] basal follicle stimulating hormone >10 IU/L, [2] antral follicle count <6, and [3] female age
R38 years. Women fulﬁlling two of the three criteria were considered to have ROR, and those not meeting any criteria were considered
to have NOR. The area under the receiver operating characteristic curve was 0.594 (0.539–0.648) for the ROR group and 0.510 (0.491–
0.530) for the NOR group. A cutoff value for SDF to predict the clinical pregnancy rate (CPR) in the ROR group was 27.3%.When the SDF
exceeded 27.3%, the live-birth and implantation rates in the ROR group were statistically signiﬁcantly decreased, but the clinical
pregnancy, live-birth, and implantation rates were not affected in the NOR group. The risk of early abortion increased signiﬁcantlyUse your smartphonein the NOR group when the SDF exceeded 27.3%.
Conclusion(s): Sperm DNA fragmentation has a greater impact on IVF and ICSI outcomes
among women with ROR, so SDF testing may be of particular clinical signiﬁcance for these cou-
ples. (Fertil Steril 2015;103:910–6. 2015 by American Society for Reproductive Medicine.)
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910S perm DNA integrity is required foraccurate transmission of paternalgenetic information and has been
increasingly recognized as a promising
biomarker of male infertility. Couples
with a high percentage of sperm DNA
fragmentation (SDF) have lower levels
of natural fertility (1, 2). Furthermore,
when SDF is extensive artiﬁcial
insemination is not effective (3).
Many studies have been perfor-
med to elucidate any correlation be-
tween SDF and clinical outcomes ofVOL. 103 NO. 4 / APRIL 2015
Fertility and Sterility®conventional in vitro fertilization (IVF) and intracytoplasmic
sperm injection (ICSI) (3–12). Some researchers have
suggested that there is a strong negative correlation
between SDF and the rates of fertilization, embryo
development, implantation, and pregnancy (5, 8, 10, 12–14).
Others have found no association between SDF and
fertilization rate or embryo development, but have suggested
an association between SDF and pregnancy (3, 6) or
pregnancy loss (7). Furthermore, some studies have found no
adverse effects of SDF on any clinical outcomes in IVF and
ICSI (4, 15). Several factors—such as differing methods for
detecting SDF, lack of standardized methods, varying patient
selection criteria, and limited study sample sizes—may
account for the inconsistency among study results. A meta-
analysis by Collins et al. (16) revealed a small but statistically
signiﬁcant association between SDF and IVF-ICSI results, but
the associationwasnot strong enough toprovidea clinical indi-
cation for the routine use of SDF testing in an infertility evalu-
ationofmen.However, some subgroupsof coupleswith speciﬁc
clinical characteristics may merit SDF testing once a strong as-
sociation between SDF and IVF-ICSI results has been
demonstrated.
Although the sperm chromatin structure assay (SCSA) is
the most commonly used method to examine SDF, other
methods such as terminal deoxynucleotidyl transferase-
mediated terminal uridine nick-end labeling (TUNEL), the
Comet assay, and sperm chromatin dispersion (SCD) have
also been introduced into clinical practice. The SCD test,
which is the simplest and least expensive method, can be per-
formed using bright-ﬁeld microscopy. Results obtained from
the SCD test correlate well with those from other DNA integ-
rity tests, such as SCSA and TUNEL (17–19). A recent study by
Zhang et al. (19) suggested both TUNEL and SCD methods are
effective, but the SCD appears to be more sensitive in
detecting DNA damage. Recently, reports have proposed
that the SCD test is useful for predicting IVF outcomes such
as embryo development, fertilization rate (12, 14), and
pregnancy rate (20). On the other hand, Anifandis et al. (21)
suggested there is no correlation between embryologic data
or pregnancy rate and SDF measured by the SCD test.
We investigated the effect of SDF, asmeasured by the SCD
test, on the clinical outcomes of IVF and ICSI cycles in women
with different ovarian reserves. We determined whether SDF
has a greater impact on IVF and ICSI outcomes in certain sub-
groups, such as women with reduced ovarian reserve (ROR).MATERIALS AND METHODS
Study Population
The study was approved by the medical ethics committees of
our hospital. Data from a cohort of 2,865 consecutive women
aged 20.5–46.5 years who underwent their ﬁrst IVF (n ¼
2,085) or ICSI (n ¼ 780) cycle between April 2009 and
December 2012 at our reproductive medicine center were
respectively analyzed in this study. Female patients with uter-
ine pathology, including uterine synechia, adenomyosis, my-
oma, or other uterine abnormalities, were excluded from the
study. Male patients who received vitamins, carnitine, or Chi-
nese medicine before IVF and ICSI were excluded as well.VOL. 103 NO. 4 / APRIL 2015Sperm Analysis and SCD Test
Routine semen analysis and SDF assessment using an SCD test
were performed 1–2 months before the initial treatment in all
2,865 cycles. Samples were collected by masturbation after 2
to 5 days of abstinence. After liquefaction, the samples were
examined for concentration andmotility according to theWorld
HealthOrganization (WHO) laboratorymanual for the examina-
tion and processing of human semen (22). Sperm morphology
was evaluated following Tygerberg's strict criteria (23).
Each SCD assay was performed using the Halosperm kit
(INDAS Laboratories) with a slight modiﬁcation. In brief, the
sperm concentration was diluted to 5–10million per milliliter.
The total volume was split into 30-mL aliquots on agarose
gel in tubes that were placed in a water bath at 90–100C for
5 minutes to fuse. The tubes were then placed in a water
bath at 37C for temperature equilibration. Next, 18 mL of
the semen sample was added to each tube and mixed with
the 30 mL of fused agarose, then 18 mL of the semen-agarose
mixture was pipetted onto a precoated slide and covered
with an18 18-mmcoverslip. The slidewas placed in a refrig-
erator at 4C for 5 minutes to allow the agarose to produce a
microgel embedded with sperm cells. The coverslip was gently
removed, and the slide was immediately immersed in an acid
solution for 7 minutes. Next, the slide was immersed in lysing
solution for 25 minutes. After 5 minutes of washing in a tray
with abundant distilled water, the slide was dehydrated in
increasing concentrations of ethanol (70%, 90%, and 100%)
for 2 minutes each, and was then air dried.
For bright-ﬁeld microscopy, each slide was covered with
a mixture of Wright's staining solution and phosphate buffer
solution (1:1) for 5–10 minutes. The slide was brieﬂy washed
in running water for 10 seconds and allowed to dry. Strong
staining is preferred to achieve easy visualization of the pe-
riphery of the dispersed DNA loop halos. A minimum of 400
spermatozoa for each patient was scored according to the pat-
terns established by Fernandez et al. (17). Sperm nuclei with
fragmented DNA produce very small or no halos of dispersed
DNA, whereas nuclei without DNA fragmentation release
their DNA loops to form large halos. The percentage of sperm
with very small or no halos was deﬁned as the SDF level.IVF and ICSI Procedures
The standard luteal long down-regulation protocol (LP) or
the short ﬂare-up protocol (SP) (24) was used in all treat-
ment cycles. Brieﬂy, with the LP a 0.5–0.9 mg depot of
gonadotropin-releasing hormone (GnRH) agonist (Diphere-
line, 3.75 mg; Ipsen Pharma Biotech) was given in the midlu-
teal phase of the preceding menstrual cycle. Stimulation with
gonadotropin (Gonal-F; EMDSerono)was begun after 14 days
(usually on cycle day 3–9) from the injection of Diphereline
when pituitary down-regulation was achieved. Down-
regulation was veriﬁed by an endometrial lining of 5 mm or
thinner, a serum estradiol <50 pg/L, and a serum luteinizing
hormone (LH) level <5 U/L. When SP was used, the GnRH
agonist (Decapetyl, 0.1 mg; Ferring GmbH) was administered
as a daily dose of 0.1 mg beginning cycle day 2 followed by
gonadotropin (Gonal-F; EMD Serono) beginning on day 3.
For both protocols, daily doses of 150 U or 225 U Gonal-F911
ORIGINAL ARTICLE: ANDROLOGYwere given for the ﬁrst 5–6 days, and then adjusted according
to follicle growth and the serum estradiol level. Human chori-
onic gonadotropin (hCG) 5,000–10,000 IU was administered
when at least three follicles had reached 17 mm in diameter,
and oocyte retrieval was performed 34–36 hours later.
The strategy for choosing the stimulation regimen was
that LP was used in women with normal ovarian reserve
(NOR) and SP in those with ROR. We used SP in women
who fulﬁlled one of the three following criteria: [1] basal
follicle-stimulating hormone (FSH) level of >10 IU/L, [2]
antral follicle count (AFC) of <6, and/or [3] age R38 years.
Otherwise, LP was used. Therefore, women treated with LP
were considered to have NOR. In this study, women who
met at least two of the three criteria above were considered
to have ROR and were included in the ROR group.
All IVF and ICSI procedures were performed according to
standard protocols (24). We used ICSI when the sperm con-
centration was less than 5  106/mL or when the motility
was <10%. Each embryo transfer was performed on day 3
after oocyte retrieval. Embryo quality was assessed on day 2
after fertilization using the grading system described by
Simon et al. (9). The embryo cumulative score was calculated
by multiplying the embryo grade (A¼ 4, B ¼ 3, C¼ 2, D¼ 1,
and E ¼ 0) by the number of blastomeres for each embryo.
When a patient had more than one embryo, a mean of all em-
bryos was calculated to obtain the total quality of all day-2
embryos. Clinical pregnancy was deﬁned as the presence of
a uterine fetal heart beat conﬁrmed by ultrasound 4 to 5weeks
after embryo transfer. Early abortion was deﬁned as sponta-
neous abortion earlier than 20 weeks of gestation.Statistical Analysis
Continuous variables were presented as mean and standard
deviation (SD), with independent t test or Mann-Whitney U
test used for comparisons between pregnant and nonpregnant
groups according to the normality of the data. The
Kolmogorov-Smirnov test was performed to detect the
normality of the data.
A receiver operating characteristic (ROC) curve analysis
was performed to determine the prognostic accuracy of SDF
as well as the cutoff point for predicting pregnancy in theTABLE 1
Baseline characteristics of the study population and clinical outcomes.
Characteristic
NOR
Pregnant Nonpregnant
Transfer cycles (n) 1,401 1,137
SDF (%) 18.4  14.4 18.3  13.5
Female age (y) 30.2  3.4 30.7  3.5
Male age (y) 32.7  4.2 33.1  4.3
Retrieved oocytes (n) 11.3  5.0 10.8  5.0
Fertilization rate (%) 74.2  18.3 70.4  20.8
Cleavage rate (%) 96.8  7.9 94.7  12.5
Day-2 embryo quality score 8.6  3.6 7.5  3.6
Embryos transferred (n) 2.2  0.4 2.1  0.5
Note: NOR ¼ normal ovarian reserve; ROR ¼ reduced ovarian reserve; SDF ¼ sperm DNA fragment
Jin. Sperm DNA fragmentation and ovarian reserve. Fertil Steril 2015.
912NOR and ROR groups. The sensitivity, speciﬁcity, positive pre-
dictive value, and negative predictive value were calculated
for the cutoff points.
Univariate and multivariate logistic regressions were per-
formed to determine the factors affecting clinical outcomes,
including the clinical pregnancy rate (CPR), live-birth rate
(LBR), and early abortion rate. Odds ratios (ORs) and 95% con-
ﬁdence intervals (95% CI) were calculated to present the effect
of the threshold SDF value. Univariate and multivariate linear
regressions were performed to determine the factors affecting
the implantation rate (IR), with b values and 95% CIs calcu-
lated to present the effect of the threshold SDF value. The var-
iables included female age, retrieved oocytes, fertilization
rate, cleavage rate, day-2 embryo quality score, number of
embryos transferred, and the treatment type (IVF or ICSI).
Confounders were the variables found to be statistically
signiﬁcantly correlated with clinical outcomes in univariate
models. The adjusted OR or adjusted b with 95% CI were pre-
sented after adjustment for the confounders by the multivar-
iate logistic or linear regression model. P< .05 was considered
statistically signiﬁcant. Data analyses were performed with
SPSS 17.0 (SPSS, Inc.), and ROC analyses were performed
with MedCalc statistical software (ver. 11.4.2.0; MedCalc
Software).RESULTS
Among the 2,865 consecutive cycles studied, the mean age of
women in the ROR group (n ¼ 327) was statistically signiﬁ-
cantly higher than that in the NOR group (n ¼ 2,538) (36.1
 4.4 vs. 30.4  3.5 years, respectively; P< .01). Statistically
signiﬁcantly fewer oocytes were retrieved in the ROR and
NOR groups (3.9  2.1 vs. 11.1  5.0, respectively; P< .01).
The CPR in the NOR group was 55.2%, and in the ROR group
was 22.0% (P< .01). There was no difference in CPR between
the 2,085 IVF cycles and 780 ICSI cycles (51.4% vs. 51.7%,
respectively; P>.05).
The characteristics of the ROR and NOR groups catego-
rized as pregnant and nonpregnant cycles are shown in
Table 1. There were statistically signiﬁcant differences be-
tween pregnant and nonpregnant cycles in the NOR group
with respect to female age, male age, number of retrievedROR
P value Pregnant Nonpregnant P value
72 255
.195 14.8  6.9 21.0  15.9 < .001
< .001 35.5  3.4 36.7  4.7 .061
< .01 37.9  5.3 38.2  5.2 .660
< .01 4.3  2.3 4.0  2.4 .302
< .001 82.8  19.4 75.2  24.9 < .01
< .001 97.4  7.8 95.8  14.2 .204
< .001 9.3  3.6 8.4  4.4 .099
< .001 2.3  0.7 2.0  0.8 < .001
ation.
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ity scores, and number of embryos transferred. In the ROR
group, there were statistically signiﬁcant differences of SDF
and number of embryos transferred between pregnant and
nonpregnant cycles.Effect of SDF on the Clinical Outcomes of IVF and
ICSI in the ROR Group
According to the ROC curve analyses (Fig. 1A; Table 2), the
SDF was statistically signiﬁcant as a prognostic predictor of
clinical pregnancy in the ROR group, with the area under
the ROC curve (AUC) 0.594 (95% CI, 0.539–0.648;
P¼ .0066). The value with the best ratio of sensitivity and
speciﬁcity was 27.3%, which was used as the cutoff value
(see Table 2). As shown in Table 3, the adjusted OR (95% CI)
for CPR and LBR, and adjusted b (95% CI) for IR were 0.16
(0.05–0.54; P< .05), 0.07 (0.01–0.49; P< .05), and 11.30
(18.50 to4.10; P< .05), respectively, all of which were sta-
tistically signiﬁcant when the SDF exceeded 27.3% in the
ROR group.Effect of SDF on the Clinical Outcomes of IVF and
ICSI in the NOR Group
In the NOR group, the AUC was 0.510 (95% CI, 0.491–0.530;
P>.05) (see Fig. 1B; Table 2), and no optimum cutoff
threshold value could be obtained. When the SDF was
>27.3%, the adjusted OR (95% CI) for CPR and LBR, and
adjusted b (95% CI) for IR were not statistically signiﬁcant
(see Table 3). These results indicate that SDF was not an opti-
mum prognostic predictor of CPR, LBR, or IR in the NOR
group. However, the adjusted OR of 1.56 (95% CI, 1.05–
2.32; P< .05) for the early abortion rate was statistically
signiﬁcant, suggesting that a high SDF signiﬁcantly increased
the risk of early abortion in the NOR group.FIGURE 1
(A) Receiver operating characteristic (ROC) curve for sperm DNA fragmenta
ROC curve (AUC) 0.594 (95% CI, 0.539–0.648) (P¼.0066). (B) ROC curve f
0.491–0.530) (P¼.373).
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Many studies have been conducted to investigate whether
SDF has a negative effect on IVF and ICSI outcomes (25).
Some early studies did not clearly describe the ovarian status
of the patients (4, 5, 13, 26, 27), and other studies included
only female patients with NOR (6–9) or studied egg donors
(11, 15, 28). Indeed, the pooling of women with different
ovarian reserves could represent a major confounding
factor in the analysis of the effect of SDF on IVF and ICSI
outcomes. Furthermore, the effect of SDF on IVF and ICSI
outcomes in women with ROR has not been reported
previously. We investigated the effect of SDF level on IVF
and ICSI clinical outcomes in women with ROR compared
with those with NOR.
In our study, women with a high basal FSH level, older
age, or decreased AFC were treated with the SP, whereas those
considered to have NOR were treated with LP (29, 30). Women
meeting at least two of the three indications (and thus with the
greatest probability of having ROR) were categorized into the
ROR group. The group's ROR status was conﬁrmed by their
having signiﬁcantly fewer oocytes retrieved and an older
mean age compared with the NOR group.
A ROC curve analyses found that the best AUC was statis-
tically signiﬁcant for the ROR group, but was not statistically
signiﬁcant for the NOR group. When SDF was >27.3%, the
CPR, LBR, and IR were statistically signiﬁcantly decreased
in the ROR group but not in the NOR group. These ﬁndings
clearly indicate a negative effect of SDF on CPR, LBR, and
IR after IVF and ICSI in women with ROR that is not present
in women with NOR.
Reduced ovarian reserve, a poor response to ovarian hy-
perstimulation, has been suggested to be related to reduced
oocyte quality (31–33). Using pregnancy loss as a marker of
oocyte quality, several studies found that pregnancy loss is
signiﬁcantly increased in women with elevated FSH levelstion (SDF) in the reduced ovarian reserve (ROR) group. Area under the
or SDF in the normal ovarian reserve (NOR) group. AUC 0.510 (95% CI,
913
TABLE 2
Prognostic accuracy of sperm DNA fragmentation to predict the clinical pregnancy rate.
Statistical characteristic
NOR ROR
Pregnant Nonpregnant P value Pregnant Nonpregnant P value
SDF (%) 18.4  14.4 18.3  13.5 .915 14.8  6.9 21.0  15.9 .001
Area under ROC curve, (95%CI) 0.510 (0.491–0.530) .373 0.594 (0.539–0.648) .0066
Cutoff (%) – 27.3
Sensitivity (%), (95% CI) – 98.6 (92.5–100.0)
Speciﬁcity (%), (95% CI) – 24.3 (19.2–30.1)
Positive predictive value (%) 55.11 31.54
Negative predictive value (%) 41.66 68.18
Note: CI ¼ conﬁdence interval; NOR ¼ normal ovarian reserve; ROR ¼ reduced ovarian reserve; SDF ¼ sperm DNA fragmentation; ROC ¼ receiver operating characteristic.
Jin. Sperm DNA fragmentation and ovarian reserve. Fertil Steril 2015.
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a clear association has been established between female aging
and poor oocyte quality, mainly due to aneuploidy (34).
Several studies have also suggested a relationship between
ROR and Down syndrome (35–37), possibly due to
aneuploidy of the oocyte. Reduced ovarian reserve may
harm the quality of remaining oocytes via elevated FSH (30,
38), oxidative stress (39), or defective microcirculation or
granulose cell function (40). Thus, in this study the oocytes
retrieved from the ROR group, as a whole, may have been of
lower quality compared with those from the NOR group.
The quality difference in oocytes retrieved from the ROR
andNOR groups in this studymay explain the differing effects
of SDF on the IVF and ICSI results in the two groups. Oocytes
have been shown to have the capability to repair damaged
DNA of spermatozoa in murine models (41–43). Although
there is no direct evidence of such a repair mechanism in
human oocytes, some studies using oocyte-donor IVF have
suggested that the effect of SDF level on IVF and ICSI preg-
nancy outcome depends on oocyte quality (15, 28). In a
study using oocytes from infertile patients, Meseguer et al.
(28) reported that increased SDF had a statistically
signiﬁcant negative impact on the likelihood of pregnancy
in IVF and ICSI cycles, whereas SDF did not have a
statistically signiﬁcant effect on oocyte donor cycles (28).TABLE 3
Multivariate analyses of the association of sperm DNA fragmentation and
Outcome Group
Adjusted OR
(95% CI) Adjusted b (95% CI)
Clinical
pregnancy
NOR 1.14 (0.91–1.42) –
ROR 0.16 (0.05–0.54) –
Live birth NOR 0.99 (0.80–1.25) –
ROR 0.07 (0.01–0.49) –
Early abortion NOR 1.56 (1.05–2.32) –
ROR 24.47 (0.80–750.48) –
Implantation
(rate)
NOR – 0.82 (3.20 to 4.84)
ROR – 11.30 (18.50 to 4.10
Note: Reference is sperm DNA fragmentation <27.3%. CI ¼ conﬁdence interval; NOR ¼ normal o
Jin. Sperm DNA fragmentation and ovarian reserve. Fertil Steril 2015.
914Thus, the likelihood of failure or incomplete repair of SDF
in fertilized oocytes from the ROR group was likely much
higher than in the NOR group. This would result in a greater
compromise of developmental capability of the resultant
embryos in the ROR group, resulting in a decreased IR, CPR,
and LBR.
The results of the NOR group in this study are not consis-
tent with those of several studies conducted on women with
NOR (6, 7, 9). Frydman et al. (6) found that the IR and CPR
of IVF in women with NOR were signiﬁcantly decreased in
a group with higher SDF levels. With IVF using healthy and
high-quality donor oocytes, Nunez-Calonge et al. (11) found
that SDF affected pregnancy results. Our results, however, are
in accordance with those of two other studies, which reported
no negative impact of SDF on clinical outcomes of IVF and
ICSI using donor oocytes (15, 28).
In our retrospective study, the risk of early abortion
increased signiﬁcantly in the NOR group, but not in the
ROR group, when SDF exceeded 27.3%. Most previous
studies did not have a large enough sample size to achieve
statistically signiﬁcant results (7). In our study, the increased
risk of early abortion reaching statistical signiﬁcance was
probably due to the large sample size of the NOR group.
This result is in agreement with the meta-analysis of Zini
et al. (44). The small sample size of the ROR group may beclinical outcomes.
P Value Confounders adjusted
.356 Female age, retrieved oocytes, cleavage rate, day-embryo
quality score, embryos transferred
.002 Female age
.605 Female age, retrieved oocytes, cleavage rate, day-embryo
quality score, embryos transferred
.008 Female age, embryos transferred
.007 None
.069 None
.832 Female age, retrieved oocytes, cleavage rate, day-2
embryo quality score, embryos transferred
) .022 Female age
varian reserve; OR ¼ odds ratio; ROR ¼ reduced ovarian reserve.
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signiﬁcance.
Some studies have reported that high levels of SDF inﬂu-
enced IVF results but did not impact ICSI outcomes (7, 45). To
the contrary, some studies have reported that SDF affected the
ICSI outcomes but not IVF outcomes (10, 13). In our study,
multivariate regression analysis did not ﬁnd that treatment
method (IVF or ICSI) was an independent confounding
factor with respect to the association of SDF and clinical
outcomes. Bungum et al. (3) reported a signiﬁcantly higher
IR and CPR with ICSI compared with IVF for patients with
higher SDF levels, and recommended that ICSI be used
when SDF exceeds 30%. However, such a recommendation
should be considered cautiously because the most likely
reason for the lack of impact of SDF on ICSI results is better
ovarian reserve in the ICSI cycle, rather than the
insemination method used.
Several researchers have tried to determine a SDF
threshold to predict clinical outcomes of IVF and ICSI using
the SCSA, TUNEL, and Comet assays (6, 7, 9). The threshold
for predicting failure to achieve pregnancy was 27.3% in the
ROR group using the SCD method in this study, which is
comparable to a threshold of 25.5% found in another
study using the SCD (46). In that study, the mean age of
the population was 36.16  4.48 years, which is also
comparable to the age of our ROR group. A reference
value of SDF for the prediction of compromised clinical
outcomes of IVF and ICSI may, at least, depend on oocyte
quality and thus is variable in different subgroups of
women. Nevertheless, our study has shown that SDF
examination is especially useful in men whose partners
have ROR.
A weakness of our study is that SDF was measured on
neat semen samples 1 to 2 months before the initiation of
IVF or ICSI. The SDF level may have changed over this time
period in some patients, although several studies have shown
that SDF level remains stable over a long period of time
(10, 47). In most previous studies, the SDF level was tested
on sperm collected the day of oocyte retrieval (4, 6–8).
However, Virro et al. (48) examined SDF using SCSA on
semen samples collected before egg retrieval and found that
SDF was related to fertilization, blastocyst development,
and ongoing pregnancy in IVF and ICSI cycles.
Furthermore, Speyer et al. (10) used SCSA testing on neat
semen samples collected before egg retrieval and found a
decrease in IR after ICSI with sperm with high SDF levels.
Nevertheless, our results and the results of these studies
indicate that SDF tested using raw samples before initiation
of IVF and ICSI treatment is helpful in predicting the
clinical outcomes of IVF and ICSI.
In conclusion, the results of our study show that SDF has
a negative impact on the clinical outcomes of IVF and ICSI,
especially in women with ROR. Oocyte quality might be the
pivotal determinant for the negative effect of SDF. Our ﬁnd-
ings suggest that SDF testing is especially useful for couples
with ROR and high SDF levels seeking IVF and ICSI. Some
studies have shown that certain medical treatments could
be helpful in alleviating SDF (49, 50). However, further
research is warranted to determine the usefulness of theseVOL. 103 NO. 4 / APRIL 2015treatments in improving the clinical outcomes of IVF and
ICSI in couples with ROR and high SDF levels.REFERENCES
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